Session 105 - 12th CROI

Home

Session 105 Poster Abstracts
Response to Antiretroviral Therapy in Developing Countries
Wednesday, 1:30 - 3:30 pm
Hall A

620	Rate and Predictors of Optimal Virologic Response to Antiretroviral Therapy in Colombia Carlos DiazGranados*^1,2,3, A Silva⁴, A Bermudez³, D Roncancio³, P Diruggiero⁵, and M Mantilla³ ¹Emory Univ AIDS Intl Training and Res Prgm, Atlanta, GA, USA; ²Fndn Univ de Ciencias de la Salud, Bogota, Colombia; ³Saludcoop EPS, Bogota, Colombia; ⁴Saludcoop EPS, Medellin, Colombia; and ⁵Saludcoop EPS, Barranquilla, Colombia
621	Response to ARTin a Multi-country HIV Care and Treatment Program in Resource-limited Countries Patricia Toro*, E Abrams, J Austin, and W El-Sadr Columbia Univ, New York, NY, USA
622	Factors Associated with Changes in CD4 ⁺T cells in highly active antiviral therapy -naïve Sub-Saharan African HIV-infected Adults J Duvignac¹, X Anglaret¹, A Kpozehouen¹, S Toure², A Inwoley², Rodolphe Thiébaut*¹, and ANRS 1203 Study Group ¹INSERM, Bordeaux, France and ²PACCI, Abidjan, Côte d'Ivoire
623	Scaling-up Antiretroviral Therapy Use for HIV- positive Adults in Southwestern Nigeria Adeyemi Adedayo*¹, A Modupeola¹, A Timothy², and HIV Positive Adults ¹Hlthmatch Intl, Lagos, Nigeria and ²Lifecare Clin Lab, Lagos, Nigeria
624	Present Status and Evolution of Mortality of an HIV-infected Population Cared for at a Comprehensive HIV/AIDS Center in Chile Marcelo Wolff*, R Northland, P Alvarez, and I Flores Arriaran Fndn, San Borja Arriaran Hosp, Santiago, Chile
625a	Access to and Early Outcomes of a Public South African Adult Antiretroviral Clinic J Hudspeth¹, Willem Venter*², A van Rie³, J Wing⁴, and C Feldman⁵ ¹Washington Univ Sch of Med, St Louis, MO, USA; ²Univ of the Witwatersrand, Johannesburg, South Africa; ³Univ of North Carolina at Chapel Hill, Sch of Publ Hlth, USA; ⁴Johannesburg Hosp, Univ of the Witwatersrand, South Africa; and ⁵Johannesburg Hosp, Univ of the Witwatersrand, South Africa
625B	Clinical and Virological Outcomes of Patients on HAART in a Large-scale Simplified Treatment Program in a Rural District of Malawi A Jeannin¹, L Pinoges², A Calmy³, J Izopet⁴, D Odhiambo¹, L Mankhambo⁵, G Karungi⁶, E Szumilin⁷, J M Tassié², C Brasher⁷, S Balandine², G Fedida⁷, N Ford⁸, and Laurent Ferradini*² ¹Médecins Sans Frontières, Chiradzulu, Malawi; ²Epicentre, Paris, France; ³Access Campaign, Geneva, Switzerland; ⁴Purpan Hospital, Toulouse, France; ⁵Ministry of Health, Chiradzulu, Malawi; ⁶Epicentre, Kampala, Uganda; ⁷Médecins Sans Frontières, Paris, France; and ⁸Médecins Sans Frontières, London, United Kingdom